vs

Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and VARONIS SYSTEMS INC (VRNS). Click either name above to swap in a different company.

VARONIS SYSTEMS INC is the larger business by last-quarter revenue ($173.1M vs $148.5M, roughly 1.2× OPKO HEALTH, INC.). On growth, VARONIS SYSTEMS INC posted the faster year-over-year revenue change (26.9% vs -19.2%). VARONIS SYSTEMS INC produced more free cash flow last quarter ($49.0M vs $-28.6M). Over the past eight quarters, VARONIS SYSTEMS INC's revenue compounded faster (15.2% CAGR vs -7.5%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Varonis Systems, Inc. is a software company based in Miami, Florida with R&D offices in Herzliya, Israel. The company’s Data Security Platform analyzes data and data activity using the insights to identify data exposure risks stemming from access permissions and software-as-a-service (SaaS) app configurations, triggering automated remediation capabilities in response.

OPK vs VRNS — Head-to-Head

Bigger by revenue
VRNS
VRNS
1.2× larger
VRNS
$173.1M
$148.5M
OPK
Growing faster (revenue YoY)
VRNS
VRNS
+46.1% gap
VRNS
26.9%
-19.2%
OPK
More free cash flow
VRNS
VRNS
$77.6M more FCF
VRNS
$49.0M
$-28.6M
OPK
Faster 2-yr revenue CAGR
VRNS
VRNS
Annualised
VRNS
15.2%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OPK
OPK
VRNS
VRNS
Revenue
$148.5M
$173.1M
Net Profit
$-31.3M
Gross Margin
43.1%
76.0%
Operating Margin
-25.8%
-1.7%
Net Margin
-21.1%
Revenue YoY
-19.2%
26.9%
Net Profit YoY
-322.8%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPK
OPK
VRNS
VRNS
Q1 26
$173.1M
Q4 25
$148.5M
$173.4M
Q3 25
$151.7M
$161.6M
Q2 25
$156.8M
$152.2M
Q1 25
$150.0M
$136.4M
Q4 24
$183.6M
$158.5M
Q3 24
$173.6M
$148.1M
Q2 24
$182.2M
$130.3M
Net Profit
OPK
OPK
VRNS
VRNS
Q1 26
Q4 25
$-31.3M
$-27.8M
Q3 25
$21.6M
$-29.9M
Q2 25
$-148.4M
$-35.8M
Q1 25
$-67.6M
$-35.8M
Q4 24
$14.0M
$-13.0M
Q3 24
$24.9M
$-18.3M
Q2 24
$-10.3M
$-23.9M
Gross Margin
OPK
OPK
VRNS
VRNS
Q1 26
76.0%
Q4 25
43.1%
78.9%
Q3 25
32.9%
78.2%
Q2 25
31.5%
79.5%
Q1 25
28.4%
78.7%
Q4 24
46.1%
83.6%
Q3 24
23.1%
83.8%
Q2 24
28.4%
82.8%
Operating Margin
OPK
OPK
VRNS
VRNS
Q1 26
-1.7%
Q4 25
-25.8%
-17.5%
Q3 25
31.7%
-22.2%
Q2 25
-38.3%
-24.0%
Q1 25
-44.8%
-32.1%
Q4 24
-18.0%
-11.1%
Q3 24
8.2%
-16.0%
Q2 24
-33.9%
-22.1%
Net Margin
OPK
OPK
VRNS
VRNS
Q1 26
Q4 25
-21.1%
-16.0%
Q3 25
14.3%
-18.5%
Q2 25
-94.7%
-23.5%
Q1 25
-45.1%
-26.2%
Q4 24
7.6%
-8.2%
Q3 24
14.3%
-12.4%
Q2 24
-5.7%
-18.4%
EPS (diluted)
OPK
OPK
VRNS
VRNS
Q1 26
Q4 25
$-0.04
$-0.23
Q3 25
$0.03
$-0.26
Q2 25
$-0.19
$-0.32
Q1 25
$-0.10
$-0.32
Q4 24
$0.02
$-0.12
Q3 24
$0.03
$-0.16
Q2 24
$-0.01
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPK
OPK
VRNS
VRNS
Cash + ST InvestmentsLiquidity on hand
$364.4M
$179.3M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$1.3B
$453.5M
Total Assets
$1.9B
$1.6B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPK
OPK
VRNS
VRNS
Q1 26
$179.3M
Q4 25
$364.4M
$883.7M
Q3 25
$412.0M
$671.3M
Q2 25
$267.3M
$770.9M
Q1 25
$428.8M
$567.6M
Q4 24
$426.6M
$529.0M
Q3 24
$400.1M
$844.8M
Q2 24
$40.6M
$582.5M
Total Debt
OPK
OPK
VRNS
VRNS
Q1 26
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Stockholders' Equity
OPK
OPK
VRNS
VRNS
Q1 26
$453.5M
Q4 25
$1.3B
$598.7M
Q3 25
$1.3B
$604.8M
Q2 25
$1.3B
$341.5M
Q1 25
$1.3B
$367.7M
Q4 24
$1.4B
$455.7M
Q3 24
$1.4B
$428.6M
Q2 24
$1.4B
$458.6M
Total Assets
OPK
OPK
VRNS
VRNS
Q1 26
$1.6B
Q4 25
$1.9B
$1.8B
Q3 25
$2.0B
$1.7B
Q2 25
$2.0B
$1.6B
Q1 25
$2.1B
$1.6B
Q4 24
$2.2B
$1.7B
Q3 24
$2.3B
$1.5B
Q2 24
$2.0B
$1.1B
Debt / Equity
OPK
OPK
VRNS
VRNS
Q1 26
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPK
OPK
VRNS
VRNS
Operating Cash FlowLast quarter
$-25.9M
$55.0M
Free Cash FlowOCF − Capex
$-28.6M
$49.0M
FCF MarginFCF / Revenue
-19.3%
28.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-190.8M
$118.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPK
OPK
VRNS
VRNS
Q1 26
$55.0M
Q4 25
$-25.9M
$24.7M
Q3 25
$-34.6M
$33.4M
Q2 25
$-83.4M
$21.3M
Q1 25
$-34.6M
$68.0M
Q4 24
$-44.4M
$24.3M
Q3 24
$-77.1M
$22.5M
Q2 24
$-26.4M
$11.7M
Free Cash Flow
OPK
OPK
VRNS
VRNS
Q1 26
$49.0M
Q4 25
$-28.6M
$20.7M
Q3 25
$-37.8M
$30.4M
Q2 25
$-86.7M
$18.0M
Q1 25
$-37.7M
$65.7M
Q4 24
$-49.8M
$19.9M
Q3 24
$-85.0M
$21.3M
Q2 24
$-33.7M
$10.9M
FCF Margin
OPK
OPK
VRNS
VRNS
Q1 26
28.3%
Q4 25
-19.3%
12.0%
Q3 25
-24.9%
18.8%
Q2 25
-55.3%
11.8%
Q1 25
-25.2%
48.1%
Q4 24
-27.1%
12.6%
Q3 24
-49.0%
14.4%
Q2 24
-18.5%
8.4%
Capex Intensity
OPK
OPK
VRNS
VRNS
Q1 26
Q4 25
1.8%
2.3%
Q3 25
2.1%
1.8%
Q2 25
2.1%
2.2%
Q1 25
2.1%
1.7%
Q4 24
2.9%
2.7%
Q3 24
4.6%
0.8%
Q2 24
4.0%
0.6%
Cash Conversion
OPK
OPK
VRNS
VRNS
Q1 26
Q4 25
Q3 25
-1.60×
Q2 25
Q1 25
Q4 24
-3.17×
Q3 24
-3.10×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

VRNS
VRNS

SaaS$161.1M93%
Term license subscriptions$6.9M4%
Maintenance and services$5.2M3%

Related Comparisons